Interestingly, a Kaplan-Meier analysis of high versus low expression of CYP27A1 increases the recurrence free survival in all BC (Fig. 9E) and this effect is also observed considering the combination HSD11B2/CYP27A1 (Fig. 9F). This evidence concerns the gene HSD11B2 and breast cancer.